세계의 정형외과용 세포치료 시장 : 규모, 점유율, 동향 분석(2025-2031년) - MedCore

Orthopedic Cell Therapy Market Size, Share, and Trend Analysis | Global | 2025-2031 | MedCore | Includes: Platlet-Rich Plasma Market and Bone Marrow Aspirate Concentrate Market

US $ 4,995 ￦ 7,227,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,995 ￦ 10,121,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,995 ￦ 13,014,000

PDF (Corporate License)

PDF 보고서를 동일 기업(해외)의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 정형외과용 세포치료 시장 규모는 2024년에 5억 5,130만 달러에 달했습니다. 이 시장은 7.2%의 CAGR로 확대하며, 2031년에는 8억 9,580만 달러에 달할 것으로 예측됩니다.

COVID-19 팬데믹으로 인해 선택적 수술이 연기되면서 일시적으로 매출이 감소했습니다. 그러나 2022년까지 시장이 회복되어 안정적 성장 궤도로 돌아갔습니다.

재생의료의 성장으로 혈소판풍부혈장(PRP)과 골수 흡인액(BMA) 요법에 대한 수요가 증가하고 있습니다. 처리 시스템의 개선으로 정형외과용 세포 치료의 효과와 채택이 강화되고 있습니다.

세계의 정형외과용 세포치료 시장에 대해 조사했으며, 시장의 개요와 시장 분석과 예측, 촉진요인과 억제요인, 경쟁 구도 등을 제공하고 있습니다.

목차

개요

• 세계의 정형외과용 세포치료 시장 개요
• 경쟁 분석
• 시장 세분화
• 대상 지역

서론

• 혈소판풍부혈장
• 농축 골수천자액

시술 건수

• 종합 정형외과 세포치료
• 혈소판풍부혈장법
• 골수천자농축 치료

시장 개요

• 부문별
• 지역별

시장 분석과 예측

• 혈소판풍부혈장 시장
• 골수천자농축액시장

건수 분석

• 혈소판풍부혈장
• 골수천자농축물

촉진요인과 억제요인

경쟁 시장 점유율 분석

KSA

영문 목차

영문목차

The global orthopedic cell therapy market was valued at $551.3 million in 2024 and is projected to grow at a CAGR of 7.2%, reaching $895.8 million by 2031.

This market includes two primary therapy types:

• Platelet-Rich Cell Therapy
• Bone Marrow Cell Therapy
• Market Insights & Data Coverage
• Unit Sales & Average Selling Prices
• Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031
• Historical Data (2021-2023)
• Competitive Landscape, Mergers & Acquisitions
• Company Profiles & Product Portfolios

Market Trends

Impact of COVID-19 on Market Growth:

• The COVID-19 pandemic caused a temporary decline in sales due to the postponement of elective procedures.

* By 2022, the market rebounded, returning to a trajectory of steady growth.

* Advancements in Cell Therapy Technology:

• Growth in regenerative medicine is driving demand for platelet-rich plasma (PRP) and bone marrow aspirate (BMA) therapies.

* Improved processing systems are enhancing the efficacy and adoption of orthopedic cell therapies.

• Increased Adoption in Orthopedics & Sports Medicine:

* Rising demand for minimally invasive treatments is fueling the market.

* Soft tissue injuries, joint reconstructions, and spine treatments are key growth areas.

Market Share Insights

Top Competitors in the Global Orthopedic Cell Therapy Market (2024):

1 Terumo

* Market leader with its Harvest Technologies division.

* Offers Harvest(R) BMAC, Harvest(R) PRP, and the Harvest(R) AdiPrep(R) adipose tissue concentrator.

* The Harvest(R) SmartPrep system enables multicellular processing for bone marrow, blood, and adipose tissue.

2 Zimmer Biomet

* Second-largest market share with its Plasmax(R) Plasma concentration system and BioCUE(TM) System.

* BioCUE(TM) System processes both bone marrow and whole blood for cell therapy applications.

3 Arthrex

* Third-largest competitor, known for its Angel(R) cPRP and Bone Marrow Processing System.

* The Angel(R) System automates the separation and concentration of PRP and BMA for orthopedic and soft tissue applications.

Market Segmentation Summary

• Platelet-Rich Cell Therapy Market

* Indications: Soft Tissue, Spine, Cardiac, Orthopedic, Plastics.

• Bone Marrow Cell Therapy Market

* Indications: Soft Tissue, Spine, Trauma, Joint Reconstructions.

Global Research Scope

• Regions Covered:

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

• Base Year: 2024
• Forecast Period: 2025-2031
• Historical Data: 2021-2023

Quantitative Coverage

• Market Size, Market Shares
• Market Forecasts, Growth Rates
• Units Sold, Average Selling Prices
• Procedure Numbers

Qualitative Coverage

• COVID-19 Impact
• Market Growth Trends & Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles & Product Portfolios
• FDA Recalls, Disruptive Technologies
• Disease Overviews

Data Sources:

• Primary Interviews with Industry Leaders
• Government Physician Data & Regulatory Data
• Hospital Private Data
• Import & Export Data
• iData Research Internal Database

TABLE OF CONTENT

• 6.1 EXECUTIVE SUMMARY
  • 6.1.1 Global Orthopedic Cell Therapy Market Overview
  • 6.1.2 Competitive Analysis
  • 6.1.3 Procedure Segmentation
  • 6.1.4 Market Segmentation
  • 6.1.5 Regions Included
• 6.2 INTRODUCTION
  • 6.2.1 Platelet-Rich Plasma
  • 6.2.2 Concentrated Bone Marrow Aspirate
• 6.3 PROCEDURE NUMBERS
  • 6.3.1 Total Orthopedic Cell Therapy Procedures
  • 6.3.2 Platelet-Rich Plasma Procedures
  • 6.3.3 Bone Marrow Aspirate Concentrate Procedures
• 6.4 MARKET OVERVIEW
  • 6.4.1 By Segment
  • 6.4.2 By Region
• 6.5 MARKET ANALYSIS AND FORECAST
  • 6.5.1 Platelet-Rich Plasma Market
  • 6.5.2 Bone Marrow Aspirate Concentrate Market
• 6.6 UNIT ANALYSIS
  • 6.6.1 Platelet-Rich Plasma Unit Analysis
    • 6.6.1.1 Platelet-Rich Plasma Units Sold by Indication
  • 6.6.2 Bone Marrow Aspirate Concentrate Unit Analysis
    • 6.6.2.1 Bone Marrow Aspirate Concentrate Units Sold by Indication
• 6.7 DRIVERS AND LIMITERS
  • 6.7.1 Market Drivers
  • 6.7.2 Market Limiters
• 6.8 COMPETITIVE MARKET SHARE ANALYSIS

관련자료